Recent Updates
Recently added Catalysts
TWST Positive Sentiment

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

Key Takeaway: Twist Bioscience Corporation announced its financial results for the third quarter of fiscal 2026, which ended on June 30, 2026. The company highlighted its growth and value in the biotech industry. Investors can access detailed reports and presentations through their website.
Price reaction · baseline $91.55 (2026-07-31 close) · hit pre-market · 3 other TWST headline(s) in the window, move may be shared
day 0 close
+10.4%
day 1
+8.6%
day 3 · peak
+19.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Twist Bioscience reported financial results for Q3 fiscal 2026.
  • The company continues to show growth and value in the biotech sector.
  • Detailed earnings report and investor presentation are available.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation(NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended June 30, 2026.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab atwww.twistbioscience.comto view thedetailed fiscal third quarter 2026 earnings reportand theinvestor presentation,or clickhttps://investors.twistbioscience.com/events-and-presentations.
The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company’s business. The conference call will be webcast live through the Investor Relations section under the “Company” tab atwww.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clickinghere. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.
We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal – more experiments, more iterations, more chances for remarkable discoveries.
Together, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all. For more information about our products and services, please visitwww.twistbioscience.com.
Follow us onLinkedIn|X|YouTube|Instagram|Bluesky

For Investors:Angela BittingSVP, Corporate Affairs925-202-6211abitting@twistbioscience.com

For Media:Amanda HoulihanCommunications Manager774-265-5334ahoulihan@twistbioscience.com

Frequently Asked Questions

What financial results did Twist Bioscience announce?

Twist Bioscience announced its financial results for the third quarter of fiscal 2026.

When did the third quarter of fiscal 2026 end?

The third quarter of fiscal 2026 ended on June 30, 2026.

Where can I find the detailed earnings report?

The detailed earnings report is available on Twist Bioscience's Investor Relations page.

What is the ticker symbol for Twist Bioscience?

The ticker symbol for Twist Bioscience is TWST.

Last updated: Aug 3, 2026